Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Non-invasive Stimulation of the Glymphatic System for Slowing Cognitive Decline

NCT: NCT07044596 · RECRUITING

NCT IDNCT07044596
StatusRECRUITING
Start Date2025-11-13
Completion2026-12

Brief Summary

The purpose of this research is to demonstrate that mild stimulation of a nerve (trigeminal nerve) in the head can modulate blood flow in the brain. The modulated blood flow will restore the flow of cerebrospinal fluid (CSF) and this in turn can help improve waste clearance in the brain and prevent build up that may lead to disease.

Frequently Asked Questions

What is Non-invasive Stimulation of the Glymphatic System for Slowing Cognitive Decline?

Non-invasive Stimulation of the Glymphatic System for Slowing Cognitive Decline is a clinical trial registered under NCT07044596. Current status: RECRUITING.

What is the status of NCT07044596?

The current status of NCT07044596 (Non-invasive Stimulation of the Glymphatic System for Slowing Cognitive Decline) is: RECRUITING.

When did Non-invasive Stimulation of the Glymphatic System for Slowing Cognitive Decline start?

Non-invasive Stimulation of the Glymphatic System for Slowing Cognitive Decline started on 2025-11-13.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑